Clinical Pharmacokinetics and Pharmacodynamics
Course, Master's level, 3FB225
Expand the information below to show details on how to apply and entry requirements.
Spring 2027 Spring 2027, Uppsala, 100%, On-campus, English
- Location
- Uppsala
- Pace of study
- 100%
- Teaching form
- On-campus
- Instructional time
- Daytime
- Study period
- 3 May 2027–6 June 2027
- Language of instruction
- English
- Entry requirements
-
150 credits, including 120 credits in biomedicine, biology, pharmaceutical sciences, chemistry and/or natural sciences/technology. Previous studies should include 5 credits of pharmacokinetics and 7.5 credits of pharmacology.
Proficiency in English equivalent to the Swedish upper secondary course English 6.
- Selection
-
Higher education credits (maximum 285 credits)
- Fees
- If you are not a citizen of a European Union (EU) or European Economic Area (EEA) country, or Switzerland, you are required to pay application and tuition fees.
- First tuition fee instalment: SEK 20,625
- Total tuition fee: SEK 20,625
- Application deadline
- 15 October 2026
- Application code
- UU-89215
Admitted or on the waiting list?
Spring 2027 Spring 2027, Uppsala, 100%, On-campus, English For exchange students
- Location
- Uppsala
- Pace of study
- 100%
- Teaching form
- On-campus
- Instructional time
- Daytime
- Study period
- 3 May 2027–6 June 2027
- Language of instruction
- English
- Entry requirements
-
150 credits, including 120 credits in biomedicine, biology, pharmaceutical sciences, chemistry and/or natural sciences/technology. Previous studies should include 5 credits of pharmacokinetics and 7.5 credits of pharmacology.
Proficiency in English equivalent to the Swedish upper secondary course English 6.
Admitted or on the waiting list?
About the course
The course gives an understanding of how pharmacokinetic (PK) and pharmacodynamic (PD) information can be applied in clinical drug development. In addition, the course gives you sufficient knowledge to be able to contribute to the planning, design and analysis of clinical studies, from a PK and PD perspective.
Teaching and training are given in data analysis, study design, simulations of clinical trials and oral presentation. The course also includes topics such as disease progression, drug effects on disease progression, and PD models that describe these processes. Software for data analysis and simulation of clinical trials and result presentations are applied during the course.
The main part of the work is performed in groups.
Syllabus
- Syllabus valid from Autumn 2026
- Syllabus valid from Spring 2026
- Syllabus valid from Spring 2024
- Syllabus valid from Autumn 2023
- Syllabus valid from Autumn 2020
- Syllabus valid from Autumn 2019
- Syllabus valid from Spring 2018
- Syllabus valid from Autumn 2017, version 2
- Syllabus valid from Autumn 2017, version 1